Showing results (1131-1140 of 1,637) with videos related to

Sort By:
Pageof 164
Brain, Behavior, and Immunity|October 30, 2016
Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogrammingRuinan Gu, Fali Zhang, Gang Chen, et al.
Biomaterials Science|June 3, 2020
Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapyMinoo J Moghaddam, Liliana de Campo, Mioko Hirabayashi, et al.
Anaesthesia and Intensive Care|September 25, 2009
The influence of gender and experience on intubation ability and technique: a manikin studyM S Waddington, M J Paech, I H S Kurowski, et al.
Organometallics|May 20, 2021
Expanding the Scope of Palladium-Catalyzed B - N Cross-Coupling Chemistry in CarboranesXin Mu, Morgan Hopp, Rafal M Dziedzic, et al.
Molecular Genetics and Metabolism|May 18, 2024
AAV-mediated expression of mouse or human GLDC normalises metabolic biomarkers in a GLDC-deficient mouse model of Non-Ketotic HyperglycinemiaKit-Yi Leung, Chloe Santos, Sandra C P De Castro, et al.
Molecular Therapy. Advances|July 12, 2026
Next generation AAV-F capsid gene therapy rescues disease pathology in a model of pyruvate dehydrogenase complex deficiencyAnna Keegan, Özge Çetin, Ellie M Chilcott, et al.
The Lancet. Child & Adolescent Health|October 21, 2021
An evidence-based framework for determining the optimal amount of intervention for autistic childrenDavid Trembath, Hannah Waddington, Rhylee Sulek, et al.
The Journal of Clinical Investigation|December 4, 2019
Impaired folate 1-carbon metabolism causes formate-preventable hydrocephalus in glycine decarboxylase-deficient miceChloe Santos, Yun Jin Pai, M Raasib Mahmood, et al.
Neurology and Therapy|August 6, 2021
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTRAaron Yarlas, Andrew Lovley, Kristen McCausland, et al.
Neuropharmacology|May 3, 2002
Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' miceK Tomiyama, F N McNamara, J J Clifford, et al.
Pageof 164